ANTIBODY-RESPONSE TO 23-VALENT PNEUMOCOCCAL VACCINE IN HIV-INFECTED CHILDREN

被引:0
|
作者
PETERS, VB [1 ]
HODES, DS [1 ]
DIAMANT, EP [1 ]
CIMINO, CO [1 ]
MADORE, DV [1 ]
机构
[1] CUNY MT SINAI SCH MED,DEPT PEDIAT,NEW YORK,NY 10029
关键词
D O I
暂无
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
引用
收藏
页码:A192 / A192
页数:1
相关论文
共 50 条
  • [1] ANTIBODY-RESPONSE AND PERSISTENCE AFTER VACCINATION OF OLDER MEN WITH 23-VALENT PNEUMOCOCCAL VACCINE
    ROWLAND, J
    MUSHER, D
    MUFSON, M
    GROOVER, J
    WATSON, D
    CLINICAL RESEARCH, 1991, 39 (04): : A843 - A843
  • [2] Evaluation of effectiveness of the 23-valent pneumococcal capsular polysaccharide vaccine for HIV-infected patients
    Breiman, RF
    Keller, DW
    Phelan, MA
    Sniadack, DH
    Stephens, DS
    Rimland, D
    Farley, MM
    Schuchat, A
    Reingold, AL
    ARCHIVES OF INTERNAL MEDICINE, 2000, 160 (17) : 2633 - 2638
  • [3] Long-Term Serological Response to 13-Valent Pneumococcal Conjugate Vaccine Versus 23-Valent Polysaccharide Vaccine in HIV-Infected Adults
    Belmonti, Simone
    Rossetti, Barbara
    Modica, Sara
    Paglicci, Lorenzo
    Borghetti, Alberto
    Ciccullo, Arturo
    Picarelli, Chiara
    Cauda, Roberto
    De Luca, Andrea
    Montagnani, Francesca
    Lombardi, Francesca
    INFECTIOUS DISEASES AND THERAPY, 2019, 8 (03) : 453 - 462
  • [4] Randomized trial of the quantitative and functional antibody responses to a 7-valent pneumococcal conjugate vaccine and/or 23-valent polysaccharide vaccine among HIV-infected adults
    Feikin, DR
    Elie, CM
    Goetz, MB
    Lennox, JL
    Carlone, GM
    Romero-Steiner, S
    Holder, PF
    O'Brien, WA
    Whitney, CG
    Butler, JC
    Breiman, RF
    VACCINE, 2001, 20 (3-4) : 545 - 553
  • [5] EVALUATION OF PNEUMOCOCCAL TITERS AND RESPONSE TO 23-VALENT PNEUMOCOCCAL POLYSACCHARIDE VACCINE IN CHILDREN WITH COUGH
    Anthony, K.
    Urrego, F.
    PEDIATRIC PULMONOLOGY, 2014, 49 : S78 - S78
  • [6] Decreased immune response to pneumococcal conjugate vaccine after 23-valent pneumococcal polysaccharide vaccine in children
    Sigurdardottir, Sigurveig Th.
    Center, Kimberly J.
    Davidsdottir, Katrin
    Arason, Vilhjalmur A.
    Hjalmarsson, Bjorn
    Elisdottir, Ragnheidur
    Ingolfsdottir, Gunnhildur
    Northington, Robert
    Scott, Daniel A.
    Jonsdottir, Ingileif
    VACCINE, 2014, 32 (03) : 417 - 424
  • [7] Revaccination with 7-valent pneumococcal conjugate vaccine elicits better serologic response than 23-valent pneumococcal polysaccharide vaccine in HIV-infected adult patients who have undergone primary vaccination with 23-valent pneumococcal polysaccharide vaccine in the era of combination antiretroviral therapy
    Lu, Ching-Lan
    Chang, Sui-Yuan
    Chuang, Yu-Chung
    Liu, Wen-Chun
    Su, Chin-Ting
    Su, Yi-Ching
    Chang, Shu-Fang
    Hung, Chien-Ching
    VACCINE, 2014, 32 (09) : 1031 - 1035
  • [8] Serologic response to primary vaccination with 7-valent pneumococcal conjugate vaccine is better than with 23-valent pneumococcal polysaccharide vaccine in HIV-infected patients in the era of combination antiretroviral therapy
    Lu, Ching-Lan
    Hung, Chien-Ching
    Chuang, Yu-Chung
    Liu, Wen-Chun
    Su, Chin-Ting
    Su, Yi-Ching
    Chang, Shu-Fang
    Chang, Sui-Yuan
    Chang, Shan-Chwen
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2013, 9 (02) : 398 - 404
  • [9] Immunogenicity and Immunological Memory Induced by the 13-Valent Pneumococcal Conjugate Followed by the 23-Valent Polysaccharide Vaccine in HIV-Infected Adults
    Farmaki, Paraskevi F.
    Chini, Maria C.
    Mangafas, Nikolaos M.
    Tzanoudaki, Marianna T.
    Piperi, Christina P.
    Lazanas, Maries Z.
    Spoulou, Vane S.
    JOURNAL OF INFECTIOUS DISEASES, 2018, 218 (01): : 26 - 34
  • [10] Effectiveness of 23-valent polysaccharide pneumococcal vaccine on pneumonia in HIV-infected adults in the United States, 1998-2003
    Teshale, Eyasu H.
    Hanson, Debra
    Flannery, Brendan
    Phares, Christina
    Wolfe, Mitchell
    Schuchat, Anne
    Sullivan, Patrick
    VACCINE, 2008, 26 (46) : 5830 - 5834